-
1Academic Journal
المؤلفون: Pullarkat, V., Cruz-Chacon, A., Gangatharan, S., Melnyk, A., Palumbo, G. A., Bellini, M., Tantravahi, S. K., Qin, Q., Potluri, J., Vachhani, P.
المصدر: HemaSphere ; volume 6, page 960-961 ; ISSN 2572-9241
-
2Academic Journal
المؤلفون: Harrison, C. N., Garcia, J. S., Somervaille, Tim C P, Foran, J. M., Verstovsek, S., Jamieson, C., Mesa, R., Ritchie, E. K., Tantravahi, S. K., Vachhani, P., O'Connell, C. L., Komrokji, R. S., Harb, J., Hutti, J. E., Holes, L., Masud, A. A., Nuthalapati, S., Potluri, J., Pemmaraju, N.
المساهمون: Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Dana-Farber Cancer Institute, Boston, MA. The Christie NHS Foundation Trust, Manchester, United Kingdom. Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom. Mayo Clinic, Jacksonville, FL. The University of Texas MD Anderson Cancer Center, Houston, TX. University of California San Diego Moores Cancer Center, La Jolla, CA. University of Texas Health San Antonio, San Antonio, TX. Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY. University of Utah and Huntsman Cancer Institute, Salt Lake City, UT. O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL. University of Southern California Keck School of Medicine, Los Angeles, CA. Moffitt Cancer Center, Tampa, FL. AbbVie Inc., North Chicago, IL.
Relation: https://dx.doi.org/10.1200/jco.21.02188; Harrison CN, Garcia JS, Somervaille TCP, Foran JM, Verstovsek S, Jamieson C, et al. Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy [Internet]. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022.; http://hdl.handle.net/10541/625096; J Clin Oncol
-
3Academic Journal
المؤلفون: Khorashad, J S, Tantravahi, S K, Yan, D, Mason, C C, Qiao, Y, Eiring, A M, Gligorich, K, Hein, T, Pomicter, A D, Reid, A G, Kelley, T W, Marth, G T, O'Hare, T, Deininger, M W
المصدر: Leukemia ; volume 30, issue 11, page 2275-2279 ; ISSN 0887-6924 1476-5551
-
4Academic Journal
المؤلفون: Mason, C C, Khorashad, J S, Tantravahi, S K, Kelley, T W, Zabriskie, M S, Yan, D, Pomicter, A D, Reynolds, K R, Eiring, A M, Kronenberg, Z, Sherman, R L, Tyner, J W, Dalley, B K, Dao, K-H, Yandell, M, Druker, B J, Gotlib, J, O'Hare, T, Deininger, M W
المصدر: Leukemia ; volume 30, issue 4, page 906-913 ; ISSN 0887-6924 1476-5551
-
5Academic Journal
المؤلفون: Eiring, A M, Page, B D G, Kraft, I L, Mason, C C, Vellore, N A, Resetca, D, Zabriskie, M S, Zhang, T Y, Khorashad, J S, Engar, A J, Reynolds, K R, Anderson, D J, Senina, A, Pomicter, A D, Arpin, C C, Ahmad, S, Heaton, W L, Tantravahi, S K, Todic, A, Colaguori, R, Moriggl, R, Wilson, D J, Baron, R, O'Hare, T, Gunning, P T, Deininger, M W
المصدر: Leukemia ; volume 29, issue 3, page 586-597 ; ISSN 0887-6924 1476-5551
-
6Academic Journal
المؤلفون: Eiring, A M, Page, B D G, Kraft, I L, Mason, C C, Vellore, N A, Resetca, D, Zabriskie, M S, Zhang, T Y, Khorashad, J S, Engar, A J, Reynolds, K R, Anderson, D J, Senina, A, Pomicter, A D, Arpin, C C, Ahmad, S, Heaton, W L, Tantravahi, S K, Todic, A, Colaguori, R, Moriggl, R, Wilson, D J, Baron, R, O'Hare, T, Gunning, P T, Deininger, M W
المصدر: Leukemia ; volume 31, issue 5, page 1253-1254 ; ISSN 0887-6924 1476-5551
-
7Academic Journal
المؤلفون: Zabriskie, M. S., Eide, C. A., Tantravahi, S. K., Vellore, N. A., Estrada, J., Nicolini, F. E., Khoury, H. J., Larson, R. A., Konopleva, M., Cortes, J. E., Kantarjian, H., Jabbour, E. J., Kornblau, S. M., Lipton, J. H., Rea, D., Stenke, L., Barbany, G., Lange, T., Hernandez Boluda, J. C., Ossenkoppele, G. J., Press, R. D., Chuah, C., Goldberg, S. L., Wetzler, M., Mahon, F. X., Etienne, G., Rousselot, P., Friedman, R., Deininger, M., Reynolds, K. R., Heaton, W. L., Eiring, A. M., Pomicter, A. D., Khorashad, J. S., Kelley, T. W., Baron, R., Druker, B. J., Deininger, M. W., O'Hare, T., BACCARANI, MICHELE, SOVERINI, SIMONA, ROSTI, GIANANTONIO
المساهمون: Zabriskie, M.S., Eide, C.A., Tantravahi, S.K., Vellore, N.A., Estrada, J., Nicolini, F.E., Khoury, H.J., Larson, R.A., Konopleva, M., Cortes, J.E., Kantarjian, H., Jabbour, E.J., Kornblau, S.M., Lipton, J.H., Rea, D., Stenke, L., Barbany, G., Lange, T., Hernandez-Boluda, J.-C., Ossenkoppele, G.J., Press, R.D., Chuah, C., Goldberg, S.L., Wetzler, M., Mahon, F.-X., Etienne, G., Baccarani, M., Soverini, S., Rosti, G., Rousselot, P., Friedman, R., Deininger, M., Reynolds, K.R., Heaton, W.L., Eiring, A.M., Pomicter, A.D., Khorashad, J.S., Kelley, T.W., Baron, R., Druker, B.J., Deininger, M.W., O'Hare, T.
مصطلحات موضوعية: Antineoplastic Agent, Catalytic Domain, Drug Resistance, Neoplasm, Fusion Proteins, bcr-abl, Human, Imidazole, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Molecular Dynamics Simulation, Mutation, Missense, Philadelphia Chromosome, Protein Binding, Protein Kinase Inhibitor, Pyridazine, Treatment Failure
وصف الملف: STAMPA
Relation: info:eu-repo/semantics/altIdentifier/pmid/25132497; info:eu-repo/semantics/altIdentifier/wos/WOS:000341873800014; volume:26; issue:3; firstpage:428; lastpage:442; numberofpages:15; journal:CANCER CELL; http://hdl.handle.net/11585/519526; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84908364892
-
8Academic Journal
المؤلفون: Eiring, A M, Page, B D G, Kraft, I L, Mason, C C, Vellore, N A, Resetca, D, Zabriskie, M S, Zhang, T Y, Khorashad, J S, Engar, A J, Reynolds, K R, Anderson, D J, Senina, A, Pomicter, A D, Arpin, C C, Ahmad, S, Heaton, W L, Tantravahi, S K, Todic, A, Colaguori, R
المصدر: Leukemia (08876924); Mar2015, Vol. 29 Issue 3, p586-597, 12p, 2 Diagrams, 1 Chart, 4 Graphs
-
9Periodical
المؤلفون: Mason, C C, Khorashad, J S, Tantravahi, S K, Kelley, T W, Zabriskie, M S, Yan, D, Pomicter, A D, Reynolds, K R, Eiring, A M, Kronenberg, Z, Sherman, R L, Tyner, J W, Dalley, B K, Dao, K-H, Yandell, M, Druker, B J, Gotlib, J, O'Hare, T, Deininger, M W
المصدر: Leukemia; April 2016, Vol. 30 Issue: 4 p906-913, 8p
Full Text Finder